Načítá se...
Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance
Following a review process lasting almost four years, and culminating in several pieces of new European legislation, adjustments have been made to the European Union's (EU) regulatory framework for pharmaceuticals. The European Commission laid out its priorities for the review as: simplifying t...
Uloženo v:
| Vydáno v: | Clin Med (Lond) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Royal College of Physicians
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4954442/ https://ncbi.nlm.nih.gov/pubmed/16521363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.6-1-87 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|